Source+10

(2010). Eu research fighting the major deadly diseases: Hiv/aids, malaria and tuberculosis. Retrieved from http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/doc/prd-catalogue-fp7_en.pdf

Facts: 1.identification in 1983 the HIV virus 2.more than 334 million people were living with HIV worldwide and approximately 2.7 million people were newly infected in 2008 3.Despite significant progress being made in improving tools to prevent and treat HIV/AIDs, this effort has not been sufficient to halt the spread of the virus or to find a definitive cure; new infections and deaths are likely to increase 4.two big Networks of Excellence (NoE) on prevention and treatment respectively, were established to better integrate and synergise HIV/ AIDs research 5.Anti-retroviral treatment in HIV-infected patients remains the only efficient way to control viral infection and represents a success of modern medicine resulting in a high reduction of AIDs mortality and HIV-associated morbidity up to now 6.several studies on cohorts of HIV-infected adults and children were funded to provide follow up and guidelines for treatment of European patients including investigation of the insurgence of resistance to anti-HIV drugs and mother-to-child transmission 7. a budget of approximately € 82 million will be committed to support research on HIV/AIDs 8.Anti-retroviral treatment in HIV-infected patients remains the only efficient way to control viral infection and represents a success of modern medicine resulting in a high reduction of AIDs mortality and HIV-associated morbidity up to now 9.About 60% of the people in sub-saharan Africa living with HIV are women 10.despite over 25 years of vaccine research a protective vaccine against HIV remains evasive and its development still faces many scientific challenges 11.current treatments are complex and require longterm administration with undesired consequences, namely drug resistance and acute and long-term toxicity 12.According to the Joint United Nations Programme on HIV/AIDs (UNAIDs), 90% of cases of HIV are transmitted through sexual contact 13.Many problems must still be overcome: some relate to the specific properties and the diversity of the virus, others to the definition of immune correlates, or the lack of appropriate small animal models 14.Accelerating the development of new HIV vaccines for therapeutic, preventive and cost-effective medical treatments <span style="font-family: 'Comic Sans MS',cursive;">15.Despite significant efforts over the past decade to design new vaccines including inactivated-live virus, peptides, proteins or non-replicative vectors, a truly effective HIV vaccine is not yet at hand